Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02693301
Other study ID # R-0031/14A
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2016
Est. completion date October 2018

Study information

Verified date February 2020
Source Universidad Europea de Madrid
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

exercise program in the pulmonary function and cardiorespiratory fitness in children with asthma and respiratory symptoms


Description:

This study aims to analyze the effects of an exercise program in the pulmonary function, cardiorespiratory fitness, diet quality index, physical activity, body composition, muscle function, agility, and psychological health in a group of children with asthma and respiratory symptoms


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date October 2018
Est. primary completion date May 2018
Accepts healthy volunteers No
Gender All
Age group 7 Years to 17 Years
Eligibility Inclusion Criteria:

- Diagnosed with Asthma following the GEMA 2009 criteria (Spanish Guide for Asthma Management) at least 6 months prior to the study.

- Complete successfully both Cardiorespiratory and Functional Tests.

Exclusion Criteria:

- Diagnosed with other chronic respiratory disease or condition

- Diagnosed with any chronic disease including cardiovascular diseases.

- Reduced mobility

- Uncooperative

- Poor adherence to medication

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise program


Locations

Country Name City State
Spain Hospital Infantil Universitario Niño Jesus Madrid

Sponsors (1)

Lead Sponsor Collaborator
Universidad Europea de Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Pulmonary Function (Lung Function) Change from baseline to 2 months, and 3 months Baseline, 2 months, and 3 months
Primary Change in Cardiorespiratory Fitness Change from baseline to 2 months, and 3 months using Cardiorespiratory Test Baseline, 2 months, and 3 months
Primary Change in Muscle Strength Change from baseline to 2 months, and 3 months using one repetition maximum test Baseline, 2 months, and 3 months
Primary Change in Quality of life and anxiety status Change from baseline to 2 months, and 3 months using the Paediatric Asthma Quality of Life Questionnaire (PAQLQ) (Guyatt GH, 1997) Baseline, 2 months, and 3 months
Primary Change in anxiety Change from baseline to 2 months, and 3 months using STAIC (State-Trait Anxiety Inventory for Children) Baseline, 2 months, and 3 months
Primary Change in Body Mass Index (BMI) Change from baseline to 2 months, and 3 months using height and weight. Baseline, 2 months, and 3 months
Primary Change in Waist-to-Height index Change from baseline to 2 months, and 3 months using height and waist. Baseline, 2 months, and 3 months
Primary Change in anthropometric outcomes Change from baseline to 2 months, and 3 months using skinfolds, and circumferences. Baseline, 2 months, and 3 months
Primary Change in Body Composition Change from baseline to 2 months, and 3 months using Bioimpedance. Baseline, 2 months, and 3 months
Primary Changes in Physical Activity using questionnaires Change from baseline to 2 months, and 3 months using Physical Activity Questionnaire for Children (PAQ-C) and Adolescents (PAQ-A) Baseline, 2 months, and 3 months
Primary Change in Agility walking Change from baseline to 2 months, and 3 months using Test of Up and Go Baseline, 2 months, and 3 months
Primary Change in Agility stairs. Change from baseline to 2 months, and 3 months using Test of Up and Down Stairs (TUDS) Baseline, 2 months, and 3 months
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device